Niyikiza Clet M. 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Dec 19, 2012
Insider Transaction Report
Form 4
Niyikiza Clet M.
EVP of Development
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2012-12-18−100,000→ 100,000 totalExercise: $2.12Exp: 2019-11-04→ Common Stock (100,000 underlying) - Exercise/Conversion
Common Stock
2012-12-18$2.12/sh+100,000$212,000→ 100,000 total
Footnotes (1)
- [F1]This option is fully vested.